MedTrace Logo

BOSTRIP: Biomarkers of Systemic Treatment Response in Psoriasis

NCT01403012 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2019-10-15

No results posted yet for this study

Summary

Metabolomics of systemic psoriasis treatment

Conditions

Interventions

OTHER

Withdrawal of venous blood samples

Withdrawal of venous blood samples (approx. 20 ml) and 2 skin biopsies (5 mm) Laboratory measurements: Fasting serum concentrations of 200 metabolites covering a biologically relevant panel of amino acids, sugars, acylcarnitines and phospholipids Genome-wide expression profiles generated from RNA derived from peripheral leukocytes

Sponsors & Collaborators

  • Technical University of Munich

    lead OTHER

Principal Investigators

  • Stephan Weidinger, Dr. med. · Dermatology, University Kiel

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2014-11-19
Completion
2015-12-04

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01403012 on ClinicalTrials.gov